2023
Oxytocin as a Biomarker of Differential Effects to SPACE vs. CBT Treatment of Child Anxiety Disorders
Zilcha-Mano S, Orbach M, Malka M, Lebowitz E. Oxytocin as a Biomarker of Differential Effects to SPACE vs. CBT Treatment of Child Anxiety Disorders. Journal Of Clinical Child & Adolescent Psychology 2023, ahead-of-print: 1-9. PMID: 37166402, PMCID: PMC10638466, DOI: 10.1080/15374416.2023.2188557.Peer-Reviewed Original ResearchSalivary OT levelsLine of researchAnxiety treatmentPositive mother-child interactionsChild anxiety treatmentChild anxiety disordersChildhood anxiety treatmentMother-child interactionMother-child dyadsHigher baseline levelsChildhood anxietyCBT treatmentGreater treatment efficacyDyadic interactionsAnxiety disordersTarget of treatmentOutcome moderatorsDisorder ScalePeripheral oxytocinEmotional Disorders (SCARED) scaleOT levelsNovel treatment targetsCBTModeratorMixed results
2016
Cross-generational influences on childhood anxiety disorders: pathways and mechanisms
Lebowitz ER, Leckman JF, Silverman WK, Feldman R. Cross-generational influences on childhood anxiety disorders: pathways and mechanisms. Journal Of Neural Transmission 2016, 123: 1053-1067. PMID: 27145763, PMCID: PMC5007197, DOI: 10.1007/s00702-016-1565-y.Peer-Reviewed Original ResearchConceptsAnxiety disordersChild anxiety treatment outcomeChild anxiety disordersChildhood anxiety disordersParent-based interventionsAnxiety treatment outcomesCross-generational influencesSocial referencingFamily accommodationChild anxietyParenting stylesVicarious learningOxytocinergic systemChildren's symptomsBehavioral systemsParental responsesParental anxietyMaternal anxietyAnxietyExistence of linksSevere distressDisordersPrenatal environmentTreatment outcomesResearch